0001562180-15-000504.txt : 20150619
0001562180-15-000504.hdr.sgml : 20150619
20150619110929
ACCESSION NUMBER: 0001562180-15-000504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150617
FILED AS OF DATE: 20150619
DATE AS OF CHANGE: 20150619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-225-4348
MAIL ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yanchik Joseph A., III
CENTRAL INDEX KEY: 0001618154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 15941647
MAIL ADDRESS:
STREET 1: C/O AILERON THERAPEUTICS INC.
STREET 2: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-06-17
false
0001404281
Tokai Pharmaceuticals Inc
TKAI
0001618154
Yanchik Joseph A., III
C/O TOKAI PHARMACEUTICALS, INC.
255 STATE STREET, 6TH FLOOR
BOSTON
MA
02109
true
false
false
false
Stock Option (right to buy)
14.04
2015-06-17
4
A
false
12000.00
0.00
A
2025-06-16
Common Stock
12000.00
12000.00
D
This option vests with respect to 100% of the shares underlying the option on June 17, 2016 subject to his continued service on Tokais Board of Directors.
/s/ Cindy Driscoll, Attorney-in-Fact
2015-06-19